Difference between revisions of "DBP3:Main"
From NAMIC Wiki
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
Back to [[Cores|NA-MIC Cores]] | Back to [[Cores|NA-MIC Cores]] | ||
__NOTOC__ | __NOTOC__ | ||
| − | {| style="background:#888" cellspacing="2" align="right" | + | {| style="background:#888; margin:20px" cellspacing="2" align="right" |
| | | | ||
| Line 14: | Line 14: | ||
Proceedings of SPIE Medical Imaging 2010. | Proceedings of SPIE Medical Imaging 2010. | ||
| − | |||
[[DPB3:Past_Featured_Articles#Gao-SPIE2010|Abstract]] | [[DPB3:Past_Featured_Articles#Gao-SPIE2010|Abstract]] | ||
Latest revision as of 16:18, 14 September 2010
Home < DBP3:MainBack to NA-MIC Cores
| ||||
DBP 3 Overview
The NA-MIC Driving Biological Problems (DBP) Core 2 identifies key biological problems to drive NA-MIC projects from 2010 to 2013. From the beginning of the NCBC project, NIH planned for a three year cycle for the DBPs. In accordance with this policy, a new set of DBP's were included in the NA-MIC competitive renewal.
DBP 3 Projects - Organized by Site
- Utah: Atrial Fibrillation
- Iowa: Huntington's disease
- MGH: Head and Neck Cancer
- UCLA: Traumatic Brain Injury
